LOX-1-mediated effects on vascular cells in atherosclerosis

Cellular Physiology and Biochemistry

Volumn 38, Issue 5, 2016, Pages 1851-1859

  Chistiakov, Dimitry A ^a   Orekhov, Alexander N ^b,c,d   Bobryshev, Yuri V ^d,e,f  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d Institute for Atherosclerosis Research   (Russian Federation)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Arteries; Atherogenesis; Atherosclerosis; Lectin like oxidized low density lipoprotein receptor 1; LOX 1; Oxidized LDL; OxLDL

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; LOW DENSITY LIPOPROTEIN; OLR1 PROTEIN, HUMAN;

APOPTOSIS; ATHEROSCLEROSIS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MACROPHAGE; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; CYTOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; SCAVENGER RECEPTORS, CLASS E;

EID: 84973161382     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000443123     Document Type: Review

References (50)

1. Rafiean-Kopaei M, Setorki M, Doudi M, Baradan A, Nasri H: Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med 2014;5:927-946.
2. Libby P: Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51.
3. Pirillo A, Norata GD, Catapano AL. LOX-1, oxLDL, and atherosclerosis. Mediators Inflamm 2013;2013:152786.
4. Dunn S, Vohra RS, Murhy JE, Homer-Vanniasinkam S, Walker JH, Ponnanbalam S: The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 2008:409:349-355.
5. Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P: LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 2013;70:2859-2872.
6. Sawamura T, Kume N, Ayoama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73-77.
7. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase H, Sawamura T, Masaki T, Hashimoto N, Kita T. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999;99:3110-3117.
8. Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T: Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res 2005;97:176-184.
9. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger P, Hermonat PL, Thomas M, Sawamura T: Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007;100:1634-1642.
10. Levitan I, Volkov S, Subbaiah PV: Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 2010;13:39-75.
11. Twigg MW, Freestone K, Homer-Vanniasinkam S, Ponhambalam S: The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease. Cardiol Res Pract 2012;2012:632408.
12. Matarazzo S, Quitadamo MC, Mango R, Ciccone S, Novelli G, Biocca S: Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption. Mol Pharmacol 2012;82:246-254.
13. Sakurai K, Cominacini L, Garbin U, Fratta Pasini A, Sasaki N, Takuwa Y, Masaki T, Sawamura T: Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J Cardiovasc Pharmacol 2004;44:S173-S180.
14. Lubrano V, Balzan S. Roles of LOX-1 in microvascular dysfunction. Microvasc Res 2016;105:132-140.
15. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, Yokode M: Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 2001;947:199-205.
16. Li D, Mehta JL: Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000;101:2889-2895.
17. Li D, Mehta JL: Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res 2009;104:566-568.
18. Khaidakov M, Wang X, Mehta JL: Potential involvement of LOX-1 in functional consequences of endothelial senescence. PLoS On. 2011;6:e20964.
19. Eto H, Miyata M, Kume N, Minami M, Itabe H, Orihara K, Hamasaki S, Biro S, Otsuji Y, Kita T, Tei C: Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun 2006;341:591-598.
20. Hinagata J, Kakutani M, Fujii T, Naruko T, Inoue N, Fujita Y, Mehta JL, Ueda M, Sawamura T: Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res 2006;69:263-271.
21. Kume N, Kita T: Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 2004;94:269-270.
22. Ding Z, Wang X, Schnackenberg L, Khaidakov M, Liu S, Singla S, Dai Y, Mehta JL: Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol 2013;168:1378-1385.
23. Schaeffer DF, Riazy M, Parhar KS, Chen JH, Duronio V, Sawamura T, Steinbrecher UP: LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res 2009;50:1676-1684.
24. Zhao M, Pan W, Shi RZ, Bai YP, You BY, Zhang K, Fu QM, Schuchman EH, He XX, Zhang GG: Acid sphingomyelinase mediates oxidized-LDL induced apoptosis in macrophage via endoplasmic reticulum stress. J Atheroscler Thromb DOI:10.5551/jat.32383.
25. Li H, Meininger CJ, Hawker J.R. Jr, Haynes TE, Kepka-Lenhart D, Mistry SK, Morris SM Jr, Wu G: Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 2001;280:E75-E82.
26. Ryoo S, Bhunia A, Chang F, Shoukas A, Berkowitz DE, Romer LH: OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 2011;214:279-287.
27. Pandey D, Bhunia A, Oh YJ, Chang F, Bergman Y, Kim JH, Serbo J, Boronina TN, Cole RN, Van Eyk J, Remaley AT, Berkowitz DE, Romer LH: OxLDL triggers retrograde translocation of arginase2 in aortic endothelial cells via ROCK and mitochondrial processing peptidase. Circ Res 2014;115:450-459.
28. Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, Lüscher TF: Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol 2011;31:2090-2097.
29. Spescha RD, Glanzmann M, Simic B, Witassek F, Keller S, Akhmedov A, Tanner FC, Lüscher TF, Camici GG: Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage. Hypertension 2014;64:347-353.
30. Li DY, Chen HJ, Mehta JL: Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res 2001;52:130-135.
31. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D: Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 2004;94:370-376.
32. Hamilton RT, Asatryan L, Nilsen JT, Isas JM, Gallaher TK, Sawamura T, Hsiai TK: LDL protein nitration: implication for LDL protein unfolding. Arch Biochem Biophys 2008;479:1-14.
33. Lu J, Yang JH, Burns AR, Chen HH, Tang D, Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH: Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res 2009;104:619-627.
34. Tang D, Lu J, Walterscheid JP, Chen HH, Engler DA, Sawamura T, Chang PY, Safi HJ, Yang CY, Chen CH: Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J Lipid Res 2008;49:33-47.
35. Imanishi T, Hano T, Sawamura T, Nishio I: Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004;31:407-413.
36. Chen JW, Zhou SB, Tan ZM: Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells. Chin Med J (Engl) 2010;123:1553-1556.
37. Honjo M, Nakamura K, Yamashiro K, Kiryu J, Tanihara H, McEvoy LM, Honda Y, Butcher EC, Masaki T, Sawamura T: Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci USA 2003;100:1274-1279.
38. Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, Sawamura T, Masaki T, Kita T: Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-αlpha. FEBS Lett 1998;440:29-32.
39. Ishiyama J, Taguchi R, Yamamoto A, Murakami K: Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells. Atherosclerosis 2010;209:118-124.
40. Li L, Sawamura T, Renier G: Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 2004;94:892-901.
41. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005;26:1700-1704.
42. Perrin-Cocon L, Coutant F, Agaugué S, Deforges S, André P, Lotteau V: Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol 2001;167:3785-3791.
43. Nickel T, Hanssen H, Sisic Z, Pfeiler S, Summo C, Schmauss D, Hoster E, Weis M: Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr 2011;50:163-172.
44. Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, Summo C, Fraunberger P, Walli AK, Pfeiler S, Weis M: oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 2009;205:442-450.
45. Sun Y, Chen X: Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species. Fundam Clin Pharmacol 2011;25:572-579.
46. Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL: LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 2008;79:287-293.
47. Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, Hashimoto N, Kita T: Oxidized LDL modulates Bax/Bcl-2 through the lectin-like Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:955-960.
48. Murugesan G, Fox PL: Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest 1996;97:2736-2744.
49. Aoyama T, Chen M, Fujiwara H, Masaki T, Sawamura T: LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett 2000;467:217-220.
50. Klouche M, Rose-John S, Schmiedt W, Bhakdi S: Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000;101:1799-1805.